-
Homepage -
Online Submission
- Artificial Intelligence in Cancer
- Artificial Intelligence in Gastroenterology
- Artificial Intelligence in Gastrointestinal Endoscopy
- Artificial Intelligence in Medical Imaging
- World Journal of Anesthesiology
- World Journal of Biological Chemistry
- World Journal of Cardiology
- World Journal of Clinical Cases
- World Journal of Clinical Infectious Diseases
- World Journal of Clinical Oncology
- World Journal of Clinical Pediatrics
- World Journal of Clinical Urology
- World Journal of Critical Care Medicine
- World Journal of Dermatology
- World Journal of Diabetes
- World Journal of Experimental Medicine
- World Journal of Gastroenterology
- World Journal of Gastrointestinal Endoscopy
- World Journal of Gastrointestinal Oncology
- World Journal of Gastrointestinal Pathophysiology
- World Journal of Gastrointestinal Pharmacology and Therapeutics
- World Journal of Gastrointestinal Surgery
- World Journal of Hematology
- World Journal of Hepatology
- World Journal of Hypertension
- World Journal of Immunology
- World Journal of Medical Genetics
- World Journal of Meta-Analysis
- World Journal of Methodology
- World Journal of Nephrology
- World Journal of Neurology
- World Journal of Obstetrics and Gynecology
- World Journal of Ophthalmology
- World Journal of Orthopedics
- World Journal of Otorhinolaryngology
- World Journal of Pharmacology
- World Journal of Psychiatry
- World Journal of Radiology
- World Journal of Respirology
- World Journal of Rheumatology
- World Journal of Stem Cells
- World Journal of Stomatology
- World Journal of Surgical Procedures
- World Journal of Translational Medicine
- World Journal of Transplantation
- World Journal of Virology
- 世界华人消化杂志
| For: | Wang ML, Zhou QL, Chen EQ, Du LY, Yan LB, Bai L, He M, Tang H. Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion. Viral Immunol 2016;29:332-42. [PMID: 27104358 DOI: 10.1089/vim.2016.0007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis] |
|---|
| Number | Citing Articles |
| 1 | Shang J, Liu H, Wen Q, M Ise R, Tu Y, Bai L, Tang H. Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancy. Int J Infect Dis 2021;105:626-31. [PMID: 33722684 DOI: 10.1016/j.ijid.2021.03.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis] |
| 2 | Zhang Y, Wang YT, Luo JX, Hu XY, Yang F, Lin W, Liang X, Zhao BJ, Zhang S, Chen YY. Effect of WSP, a Chinese Herbal Formula, on Th17/Treg Ratio and HBeAg Seroconversion in Telbivudine-Treated HBeAg-Positive Chronic Hepatitis B Patients with High Baseline ALT Levels (20-30 Times the ULN). Evid Based Complement Alternat Med 2019;2019:7260369. [PMID: 30949222 DOI: 10.1155/2019/7260369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis] |
| 3 | Pan HY, Pan HY, Song WY, Zheng W, Tong YX, Yang DH, Dai YN, Chen MJ, Wang MS, Huang YC, Zhang JJ, Huang HJ. Long-term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis. J Viral Hepat 2017;24 Suppl 1:29-35. [PMID: 29082652 DOI: 10.1111/jvh.12794] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis] |